Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Abstract: We consider the problem of translating XML queries into SQL when XML documents have been stored in an RDBMS using a schema-based relational decomposition. Surprisingly, there is no published ...

The lack of a recursion depth limit in the oracle's price calculation logic will cause a permanent Denial of Service for any misconfigured markets, affecting all users of those markets. A trusted ...

Abstract: Recursion is a fundamental computation mechanism which has been incorporated into the SQL language. This work focuses on the optimization of linear recursive queries in SQL. Query ...

As of March 31, Recursion Pharmaceuticals had a cash position of $509 million. Following Tuesday’s layoffs, the biotech expects its runway to last into the fourth quarter of 2027. Recursion ...

The results of a recent survey released Tuesday showed President Trump's actions are likely to make it harder for biotech companies like Recursion to raise capital. The company reported ...

Oracle SQL Developer is a great tool for managing Oracle Databases. It has a user-friendly interface that makes it easier to handle database tasks. The software offers features to simplify workflows ...